A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00800501
Recruitment Status : Completed
First Posted : December 2, 2008
Last Update Posted : December 6, 2011
ICON Clinical Research
Information provided by (Responsible Party):
Newron Sweden AB

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2011
  Study Completion Date : June 2011